Transcatheter Aortic Valve Implantation (TAVI)
Clinical evidence
The Medtronic CoreValve™/Evolut™ platform is supported by a robust body of clinical evidence. Explore the CoreValve™/Evolut™ clinical success.
Stay up to date on the latest clinical evidence from Medtronic. Key summaries demonstrate the efficacy of the CoreValve™/Evolut™ TAVI platform.
The CoreValve™/Evolut™ platform provides reproducible results from clinical trial to the real world.
Explore our STS/ACC TVT Registry™* data that supports the excellent clinical performance seen in our trials.
The purpose of the EXPAND TAVR II Pivotal Trial is to explore the treatment of moderate aortic stenosis (AS) with early aortic valve replacement (AVR) before AS becomes severe. This can lead to preservation of cardiac function, prevention of further deterioration in cardiac function, and prevention of death in some patients.
LinkedIn: Medtronic Cardiac and Vascular
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.